Testing effectiveness (Phase 2)Looking for participantsNCT04260256
What this trial is testing
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
Who this might be right for
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
CellSight Technologies, Inc. 40